Navigation Links
Novelda Appoints Alf-Egil Bogen as Chief Executive Officer to Lead the Company to the Next Level
Date:8/22/2013

p>

"Our strategy for the company involves a strong focus on turnkey solutions for our OEM customers. We want to help them in the design of amazing radars for medical, building automation, robots and many other applications. I am also proud of the relationship with Samsung Thales to search for land mines. If we can help saving lives with our technology that will feel very right," Bogen finishes.

ABOUT NOVELDA AS

Novelda AS is a privately held, R&D driven, Semiconductor Company, based in Norway and specializing in nanoscale wireless low-power technology for ultra-high resolution impulse radar.

The Novelda Impulse Radar is a complete CMOS radar system integrated on a single chip: a sensor for human vital sign monitoring, personal security, environmental monitoring, industrial automation and robotics. In addition to being an alternative to, or complementing existing technologies such as video, ultrasound and infrared sensors, it opens up for new application areas due to its speed and resolution, and its ability to "see through" obstacles.

Novelda was founded in 2004 as a spinout from the University of Oslo, and there is a strong Research & Development partnership with the university. www.novelda.no

High-resolution image:

Press Release Contact:   
President Dag Wisland: dag(at)novelda.no 
CMO Aage Kalsaeg: aage(at)novelda.no

Read more news from Novelda.      
'/>"/>

SOURCE Novelda AS
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. State-of-the-Art Novelda NVA6000 Impulse Radar Transceiver Finds Widespread Appeal and Applications
2. Samsung Thales signs Development Agreement with Novelda
3. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
4. Elsevier / MEDai Appoints Tom Zajac as New President
5. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
6. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
7. BioStorage Technologies Appoints New Member to Board of Directors
8. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
9. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
10. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
11. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... Xeno Diagnostics has again received an ... COLA inspection. Xeno has met all criteria for ... organization. Accreditation is earned only by laboratories that ... demonstrate continued accuracy in the performance of proficiency ... , While the Laboratory Excellence award ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
(Date:12/17/2014)... , Dec. 17, 2014 Tigercat ... Phase 2 study evaluating the investigational oral NK-1 ... patients with severe, chronic itch who are unresponsive ... care, including topical steroids and antihistamines. ... in Visual Analog Scale (VAS) itch score from ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
... Legislature are bogged down in a budget fight, just like ... is in Wisconsin. But there's an important distinction between the ... the few areas of agreement, not a source of perpetual ... and Governor Tim Pawlenty are behind schedule in most ways ...
... Congress as well as the Wisconsin Legislature, it is becoming ... research to persuade fellow lawmakers that such science is unethical. ... public opinion about its relative merits is beginning to carry ... of life and the promise of science, the House of ...
... could offer treatment for the underlying process not ... second Governor's Business Plan Contest on Tuesday, ... , ,Mithridion, a University of Wisconsin-Madison spinoff, emerged as ... for the judges. Even before that, co-founder Jeff Johnson, ...
Cached Biology Technology:Feuds between UW and the Legislature should end for good of the state 2Feuds between UW and the Legislature should end for good of the state 3With ethics guidelines, political consensus emerging on stem-cell research 2With ethics guidelines, political consensus emerging on stem-cell research 3Alzheimer's drug firm and more winners named in Wisconsin business-plan contest 2Alzheimer's drug firm and more winners named in Wisconsin business-plan contest 3Alzheimer's drug firm and more winners named in Wisconsin business-plan contest 4
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ... to expand its team and bring LaunchKey to market ...
(Date:12/17/2014)... Dec. 16, 2014 Valencell, a leader in ... biometric technology to industry leaders such as Intel, Jabra, ... validated, biometric wearable products. These products will be showcased ... Las Vegas . "Our ... flexible and robust – with the clinical data to ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Humans are having an effect on Earth,s ecosystems but it,s ... the planet we are causing. Now you can add an ... The only question is how large of an impact will ... issue of Science (Dec. 16, 2011), Arizona State ...
... Ill. Clinical gene therapy may be one step closer, ... molecules. A group of University of Illinois researchers, led ... short spiral-shaped proteins can efficiently deliver DNA segments to cells. ... Chemie. "The main idea is these are new ...
... identified a gene mutation that researchers estimate dates back to ... yet discovered. , Researchers with the Ohio State University Comprehensive ... J. Solove Research Institute led the study and estimate that ... ago. Only a mutation seen in cystic fibrosis that arose ...
Cached Biology News:Researchers assess effects of a world awash in nitrogen 2Let's do the twist: Spiral proteins are efficient gene delivery agents 2Let's do the twist: Spiral proteins are efficient gene delivery agents 3Scientists discover second-oldest gene mutation 2
... SAGE (serial analysis of gene ... expression analysis. Expression profiles generated ... to detect low-abundance transcripts making ... genes. The I-SAGE Kit is ...
Human LAIR2 Biotinylated Affinity Purified PAb...
... mycobacteria in Complete Freund's adjuvant attract macrophages ... which enhances the immuneresponse. For this reason, ... the initial injections; Incomplete Freund's adjuvant is ... in saline) are typically mixed with an ...
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
Biology Products: